Defining the clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and exploitable therapeutic target
| Autor: | Montero-Hidalgo, A.J., Gómez-Gómez, E., Galán-Cañete, M., Porcel-Pastrana, F., Pérez-Gómez, J.M., Ortega-Bellido, M., Carrasco-Valiente, J., Chamorro-Castillo, L., Campos-Hernández, J.P., Rangel-Zuñiga, O.A., González-Serrano, T., Sánchez-Sánchez, R., Sarmento-Cabral, A., Gahete, M.D., Jiménez-Vacas, Juan M., Luque, Raul M. |
|---|---|
| Zdroj: | In Molecular Therapy: Oncology November 2024 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|